DK142875B - Process for the preparation of adenine. - Google Patents

Process for the preparation of adenine. Download PDF

Info

Publication number
DK142875B
DK142875B DK171777A DK171777A DK142875B DK 142875 B DK142875 B DK 142875B DK 171777 A DK171777 A DK 171777A DK 171777 A DK171777 A DK 171777A DK 142875 B DK142875 B DK 142875B
Authority
DK
Denmark
Prior art keywords
adenine
reaction
preparation
diamino
yield
Prior art date
Application number
DK171777A
Other languages
Danish (da)
Other versions
DK142875C (en
DK171777A (en
Inventor
Michael Cornelis Vander Zwan
Donald Floyd Reinhold
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Priority to DK171777A priority Critical patent/DK142875B/en
Publication of DK171777A publication Critical patent/DK171777A/da
Publication of DK142875B publication Critical patent/DK142875B/en
Application granted granted Critical
Publication of DK142875C publication Critical patent/DK142875C/da

Links

Landscapes

  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Description

.S' (11) FREMLÆGGELSESSKRIFT 1 U2S7 5 DANMARK (51) Int. Cl.3 C 07 D 473/34 _±_ (21) Ansøgning nr. 1717/77 (22) Indleveret den 19* &pr. 1977 f(24) Løbedag 19. apr. 1977 (44) Ansøgningen fremlagt og ro fremlæggelsesskriftet offentliggjort den 1 O· f©b. 1 9°1.S '(11) PUBLICATION WRITING 1 U2S7 5 DENMARK (51) Int. Cl.3 C 07 D 473/34 _ ± _ (21) Application No. 1717/77 (22) Filed on 19 * & per. 1977 f (24) Race day 19 Apr. 1977 (44) The application submitted and the petition published on 1 O · f © b. 1 9 ° 1

DIREKTORATET FORDIRECTORATE OF

PATENT-OG VAREMÆRKEVÆSENET (30) Prioritet begæret fra den mm (71) MERCK & CO. INC., Rahway, New Jersey, US.PATENT AND TRADEMARKET SYSTEM (30) Priority requested from mm (71) MERCK & CO. INC., Rahway, New Jersey, US.

(72) Opfinder: Michael Cornells Vander Zwan, 30 Shelley Drive, Somerset, New Jersey, US: Donald Floyd Reinhold, 564 Parkview Avenue, North Plainfield,(72) Inventor: Michael Cornells Vander Zwan, 30 Shelley Drive, Somerset, New Jersey, US: Donald Floyd Reinhold, 564 Parkview Avenue, North Plainfield,

New Jersey, US.New Jersey, US.

(74) Fuldmægtig under sagens behandling:(74) Plenipotentiary in the proceedings:

Ingeniørfirmaet Hofman-Bang & Boutard.Hofman-Bang & Boutard Engineering Company.

(54) Fremgangsmåde til fremstilling af adenin.(54) Process for the preparation of adenine.

Den foreliggende opfindelse angår en særlig fremgangsmåde til fremstilling af adenin ud fra arylazomalononitril og formamid i nærværelse af ammoniak.The present invention relates to a particular process for the preparation of adenine from arylazomalononitrile and formamide in the presence of ammonia.

Adenin og β-aminopurin er et naturligt forekommende produkt, der er velkendt som mellemprodukt ved fremstilling af forskellige slutprodukter (se USA patentskrift nr. 3 846 426). Det er kendt, at adenin kan fremstilles ud fra 4,6-diamino-5-arylazopyrimidin (se Baddi-ley et al., "Jour. of the Chem. Soc." Part II (1943) side 386-387 og Cavalieri et al., "Jour. of the Am.Chem.Soc." Vol. LXXI (Jan.-April 1949) side 533-536). Det fremgår af Japansk patent publikation 2 142875 28497/73» at adenin kan fremstilles i ét trin ved omsætning mellem arylazomalononitril og formamid i nærværelse af ammoniak under samtidig katalytisk reduktion. Det har dog vist sig, at det ved denne proces fremstillede produkt er yderst urent og ikke opnås i tilfredsstillende udbytte. Dette skyldes formentlig for tidlig fjernelse af arylgruppen i arylazomalononitril ved hydrogeneringr Det resulterende aminomalononitril menes at være relativt ustabilt og dekomponere under reaktionsbetingelserne. Det fremgår endvidere af japansk patentpublikation nr. 81394, at adenin kan fremstilles ved behandling af arylazomalononitril med formamid i nærværelse af ammoniak efterfulgt af behandling af den opnåede pyri-midin med myresyre eller et derivat deraf under reducerende betingelser. Denne fremgangsmåde giver også et ret ringe udbytte af mindre ren adenin.Adenine and β-aminopurine are a naturally occurring product that is well known as an intermediate in the preparation of various end products (see U.S. Patent No. 3,846,426). It is known that adenine can be prepared from 4,6-diamino-5-arylazopyrimidine (see Baddi-ley et al., "Jour. Of the Chem. Soc." Part II (1943) pages 386-387 and Cavalieri et al. al., "Jour. of the Am.Chem.Soc." Vol. LXXI (Jan.-April 1949) pages 533-536). Japanese Patent Publication 2 142875 28497/73 discloses that adenine can be prepared in one step by reaction of arylazomalononitrile with formamide in the presence of ammonia under simultaneous catalytic reduction. However, it has been found that the product produced by this process is extremely unclean and is not obtained in satisfactory yield. This is probably due to premature removal of the aryl group in arylazomalononitrile by hydrogenation. The resulting aminomalononitrile is believed to be relatively unstable and decompose under the reaction conditions. Further, Japanese Patent Publication No. 81394 discloses that adenine can be prepared by treating arylazomalononitrile with formamide in the presence of ammonia followed by treatment of the pyrimidine obtained with formic acid or a derivative thereof under reducing conditions. This method also yields a rather poor yield of less pure adenine.

Fremgangsmåden ifølge opfindelsen, der er ejendommelig ved det i krav 11 s kendetegnende del anførte, giver yderst ren adenin i stort udbytte.The process according to the invention, which is characterized by the characterizing part of claim 11, provides extremely pure adenine in high yield.

Fremgangsmåden ifølge opfindelsen kan udføres i et opløsningsmiddel, såsom methanol, ethanol, isopropanol, cycliske og acyoliske ethere, methylenchlorid, ethylendichlorid, hexan, oxan eller de-can. Arten af opløsningsmidlet er ikke kritisk, ;men ifølge en foretrukken udførelsesform anvendes formamid som opløsningsmiddel i betydeligt overskud, såsom 10-20 mol pr. mol arylazomalononitril. Da der kun kræves et mol til reaktionen, udnyttes overskuddet kun som opløsningsmiddel. De anvendte ammoniumsalte omfatter ammoniumsalte af enhver uorganisk eller organisk syre. Eksempler herpå er ammoniumacetat, -sulfat, -iodid, -chlorid, -carbonat, -propionat og -nitrat. Saltet er fortrinsvis et ammoniumhalogenid , som er billigt og let tilgængeligt. Ammoniumsaltene ankendes sædvanligvis i mængder på mindst 0,1% efter vægt, baseret på vægten af arylazomalononitril, dog fortrinsvis 5 - 100 %, især 10 - 60 %.The process of the invention can be carried out in a solvent such as methanol, ethanol, isopropanol, cyclic and acylic ethers, methylene chloride, ethylene dichloride, hexane, oxane or decane. The nature of the solvent is not critical, but according to a preferred embodiment, formamide is used as a solvent in considerable excess, such as 10-20 moles per liter. mole of arylazomalononitrile. Since only one mole is required for the reaction, the excess is utilized only as solvent. The ammonium salts used include ammonium salts of any inorganic or organic acid. Examples are ammonium acetate, sulfate, iodide, chloride, carbonate, propionate and nitrate. The salt is preferably an ammonium halide which is cheap and readily available. The ammonium salts are usually recognized in amounts of at least 0.1% by weight, based on the weight of arylazomalononitrile, however preferably 5 - 100%, especially 10 - 60%.

Den ved reaktionen anvendte temperatur ligger sædvanligvis mellem 50°Gi og 400°C, men temperaturen kan om ønsket varieres. Hvis en særlig lang reaktionstid ikke er nogen ulempe, kan der f.eks.The temperature used in the reaction is usually between 50 ° C and 400 ° C, but the temperature can be varied if desired. If a particularly long reaction time is no disadvantage, e.g.

5 U2875 anvendes stuetemperatur, men i så fald kræves mange dage til afslutning af reaktionen. Under sædvanlige omstændigheder anvendes en temperatur mellem 90° C og 250°C, og det foretrukne område er 100 - 200°C, fortrinsvis 140 - 160°C.At room temperature, however, many days are required to complete the reaction. Under normal circumstances, a temperature between 90 ° C and 250 ° C is used, and the preferred range is 100 - 200 ° C, preferably 140 - 160 ° C.

Ved reaktionens udførelse anvendes mindst 1 mol ammoniak pr. mol arylazomalononitril, hvis optimale udbytter ønskes. Selv om der kan anvendes mindre mængder kræver reaktionen 1 mol, og enhver mindre mængde vil resultere i formindsket udbytte. Baseret på vægten af arylazomalononitril bør ammoniak være til stede i mængder fra 10 til 300%, fortrinsvis 25 til 100% efter vægt. Sædvanligvis benyttes 50 til 90%.In carrying out the reaction, at least 1 mole of ammonia is used per day. moles of arylazomalononitrile whose optimum yields are desired. Although smaller amounts can be used, the reaction requires 1 mole and any smaller amount will result in diminished yield. Based on the weight of arylazomalononitrile, ammonia should be present in amounts from 10 to 300%, preferably 25 to 100% by weight. Usually 50 to 90% is used.

Det her anvendte udtryk "aryl" benyttes om ethvert organisk radikal» der er afledt af et aromatisk carbonhydrid. Også omfattet er sådanne radikaler, som indeholder substituenter, såsom amino, halogen, alkyl, nitro, hydroxy, alkoxy, aryloxy, carboxyl eller cyano.The term "aryl" as used herein is used for any organic radical derived from an aromatic hydrocarbon. Also included are such radicals which contain substituents such as amino, halogen, alkyl, nitro, hydroxy, alkoxy, aryloxy, carboxyl or cyano.

Ved fremstilling af adenin fjernes arylgruppen tander slutreaktio-nen, og arten af denne substituent er ikke kritisk. Der kan endog anvendes substituenter, som indgår i reaktionen, da sådanne reaktioner kun resulterer i dannelsen af urenheder, når arylgruppen fjernes. Fortrinsvis er arylgruppen usubstitueret.In the preparation of adenine, the aryl group removes the final reaction and the nature of this substituent is not critical. Substituents which are part of the reaction can even be used, since such reactions only result in the formation of impurities when the aryl group is removed. Preferably, the aryl group is unsubstituted.

Ved udtrykket "derefter” skal forstås, at reaktionen af arylazomalononitril til dannelse af 4,6-diamino-5-arylazopyrimidin kan forløbe til afslutning, før pyrimidin-forbindelsen hydrogeneres til dannelse af adenin. Med andre ord gennemføres hydrogeneringsreaktionen ikke samtidig med dannelse af pyrimidin, hvilket medfører en forbedring af udbytterne og renheden.The term "then" is understood to mean that the reaction of arylazomalononitrile to form 4,6-diamino-5-arylazopyrimidine may terminate before the pyrimidine compound is hydrogenated to form adenine. , which improves yields and purity.

Ved udførelse af hydrogeneringsreaktionen kan der benyttes et vilkårligt opløsningsmiddel af den ovenfor angivne art, men også i dette tilfælde foretrækkes amid som opløsningsmiddel. Da 2 mol formamid kræves ved reaktionen for hvert mol pyrimidinforbindelse, foretrækkes det at anvende et overskud, såsom fra 4 til 20 mol formamid som reagens og opløsningsmiddel. Hvis opløsningsmidlet er det samme for begge reaktionstrin, er det unødvendigt at isolere mellemproduktet. Fortrinsvis anvendes en hydrogeneringskata 4 142875 lysator ved reaktionen i mængder på 0,1 - 10%, baseret på vægten af pyrimidinforbindelsen, foretrukkent 0,5 - 2,5% og sædvanligvis 1%. Hydrogeneringskatalysatoren kan være en vilkårlig velkendt katalysator, såsom platin, bly, Raney-nikkel, kobber, rhodium, ruthenium og alle andre metaller fra grupperne VIII, IB, IIB, VB, VIB og VTIB i det periodiske system. Andre hydrogeneringskatalysatorer kan om ønsket udvælges.In carrying out the hydrogenation reaction, any solvent of the kind mentioned above may be used, but in this case also amide is preferred as the solvent. Since 2 moles of formamide are required in the reaction for each mole of pyrimidine compound, it is preferred to use an excess such as from 4 to 20 moles of formamide as a reagent and solvent. If the solvent is the same for both reaction steps, it is unnecessary to isolate the intermediate. Preferably, a hydrogenation catalyst is used in the reaction in amounts of 0.1 - 10%, based on the weight of the pyrimidine compound, preferably 0.5 - 2.5% and usually 1%. The hydrogenation catalyst can be any well-known catalyst such as platinum, lead, Raney nickel, copper, rhodium, ruthenium and all other metals of groups VIII, IB, IIB, VB, VIB and VTIB of the periodic system. Other hydrogenation catalysts may be selected if desired.

Fremgangsmåden ifølge opfindelsen skal i det efterfølgende illustreres nærmere ved hjælp af nogle udførelseseksempler. Alle delene er udtrykt i vægtdele, med mindre andet er angivet.The process according to the invention will be illustrated in the following with the aid of some exemplary embodiments. All parts are expressed in parts by weight, unless otherwise stated.

EKSEMPEL 1EXAMPLE 1

Præparation af 4,6-diamino-5-phenvlazopyrimidin I en 500 ml autoklav blev i rækkefølge indført 2,12 g ammoniumchlo-rid (0,04 mol), 17,0 g phenylazomalononitril (0,10 mol) og 92 ml formamid. Apparatet blev skyllet med ammoniak, lukket og derefter mættet med ammoniak ved et tryk på 0,7 kg/cm . Apparatet blev derefter opvarmet under omrøring ved 1000 omdrejninger per min. til 160°C i 5 timer, idet trykket lejlighedsvis blev aflastet til p opretholdelse af 2,8 til 5,5 kg/cm . Efter afkøling til stuetemperatur blev ammoniakken udskyllet med nitrogen, de dannede orange stoffer blev frafiltreret (modervæsken blev anvendt til recirkulering) , og kagen blev først skyllet med 12 ml frisk formamid og derefter med 10 ml vand. Filterkagen blev tørret i vakuum (100°C, 20 mm Hg i tre timer) og gav 19,55 g 4,6-diamino-phenylazopyrimidin (91,4% udbytte); U.V. (0,1M HC1 i methanol)^max = 570, E% = 895, smp: 295-500°C, ækv. vægt (HC10^) 216,5 (99,0 rent), tic (silicagel, CHCl^iMeOH 6:1 efter vol.): enkelt plet.Preparation of 4,6-diamino-5-phenyllazopyrimidine In a 500 ml autoclave, 2.12 g of ammonium chloride (0.04 mol), 17.0 g of phenylazomalononitrile (0.10 mol) and 92 ml of formamide were sequentially introduced. The apparatus was rinsed with ammonia, closed and then saturated with ammonia at a pressure of 0.7 kg / cm. The apparatus was then heated with stirring at 1000 rpm. to 160 ° C for 5 hours, the pressure being occasionally relieved to maintain 2.8 to 5.5 kg / cm. After cooling to room temperature, the ammonia was purged with nitrogen, the orange substances formed were filtered off (the mother liquor was used for recycling) and the cake was first rinsed with 12 ml of fresh formamide and then with 10 ml of water. The filter cake was dried in vacuo (100 ° C, 20 mm Hg for three hours) to give 19.55 g of 4,6-diamino-phenylazopyrimidine (91.4% yield); U.V (0.1M HCl in methanol) max max = 570, E% = 895, mp: 295-500 ° C, eq. wt (HClO) 216.5 (99.0 pure), tic (silica gel, CHCl3 in MeOH 6: 1 by vol.): single stain.

EKSEMPEL 2EXAMPLE 2

Præparation af adenin. fra phenylazomalononitril I en glasklædt autoklav indføres 20 ml ethylalkohol, 4,5 g formamid, 0,55 ammoniumchlorid, 4,25 g phenylazomalononitril, 4 g ammoniak og 0,15 g Raney-nikkel. Apparatet lukkes og opvarmes til 5 142875 150°C og henstår ved denne temperatur uden rystning i 4 timer. Efter dette tidspunkt indføres hydrogen til opnåelse af et tryk på 91-98 kg/cm^ i apparatet, og reaktionen fortsættes ved 150°C under omrystning i yderligere 8 timer. Efter afkøling til stuetemperatur afdestilleres flygtige stoffer, og remanensen opløses i vand indeholdende 0,40 g natriumhydroxid. Efter omrystning i 20 minutter frafiltreres den uopløselige katalysator. Filtratet oparbejdes på sædvanlig måde (dvs. ved tilsætning af saltsyre til en pH-værdi på 7,0 og frafiltrering af faste stoffer) til opnåelse af et stof, som efter tørring i vakuum og ved 80°C udgør 3,0 g.Preparation of adenine. from phenylazomalononitrile In a glass-clad autoclave, 20 ml of ethyl alcohol, 4.5 g of formamide, 0.55 ammonium chloride, 4.25 g of phenylazomalononitrile, 4 g of ammonia and 0.15 g of Raney nickel are introduced. The appliance is closed and heated to 5 ° C and left at this temperature without shaking for 4 hours. After this time hydrogen is introduced to obtain a pressure of 91-98 kg / cm 2 in the apparatus and the reaction is continued at 150 ° C with shaking for an additional 8 hours. After cooling to room temperature, volatiles are distilled off and the residue dissolved in water containing 0.40 g of sodium hydroxide. After shaking for 20 minutes, the insoluble catalyst is filtered off. The filtrate is worked up in the usual way (ie by adding hydrochloric acid to a pH of 7.0 and filtering off solids) to give a substance which after drying in vacuo and at 80 ° C is 3.0 g.

Dette stof har samme som adenin ved tyndtlagschromatografi og udviser en enkelt plet. U.V. (N/10 HCl)Amax 263, E% 822 viser 85% renhed. Væskechromatografi (L.C.) svarer til analytisk adenin og indicerer 73,8% renhed. L.C. indicerer også, at filtratet indeholder yderligere 0,25 g adenin. Det totale udbytte korrigeret for renhed (3,0) (0,738) + 0,25 g, svarer til 2,47 g eller 73%.This substance is similar to adenine by thin layer chromatography and exhibits a single stain. U.V (N / 10 HCl) Amax 263, E% 822 shows 85% purity. Liquid chromatography (L.C.) corresponds to analytical adenine and indicates 73.8% purity. L. C. also indicates that the filtrate contains an additional 0.25 g of adenine. The total yield corrected for purity (3.0) (0.738) + 0.25 g corresponds to 2.47 g or 73%.

EKSEMPEL 3EXAMPLE 3

Præparation af 4,6-diamino-5-nhenylazopyrlmldlnPreparation of 4,6-diamino-5-nhenylazopyridine

Eksempel 1 gentages som beskrevet med den ændring, at intet am-moniumchlorid tilsættes. Efter oparbejdning på samme måde fås 19,5 g, (udbytte 91,16%) mindre rent 4,6-diamino-5-phenylazopyri-midin, U.V. (0,1N HCl)Amax = 365, E% = 786; smp: 280-297°C; ækv. vgt. (HC104) 224,8 (95,3% rent); tic, silicagel (CHCl^:Example 1 is repeated as described with the change that no ammonium chloride is added. After working up in the same way, 19.5 g (yield 91.16%) less pure 4,6-diamino-5-phenylazopyri-midin, U.V. (0.1N HCl) Amax = 365, E% = 786; mp: 280-297 ° C; eq. weight. (HClO 4) 224.8 (95.3% pure); tic, silica gel (CHCl

MeOH 6:1, efter vol.): spor af to urenheder. Dette eksempel viser, at der uden ammoniumsalt opnås et lavere udbytte, og at produktet er urent.MeOH 6: 1, by vol.): Traces of two impurities. This example shows that without ammonium salt, a lower yield is obtained and the product is impure.

EKSEMPEL 4EXAMPLE 4

Præparation af 4.6-diamino-5-phenylazopyrimidinPreparation of 4.6-diamino-5-phenylazopyrimidine

Eksempel 1 gentages som beskrevet med den ændring, at ammoniumacetat tilsættes. Efter oparbejdning på samme måde fås 19,92 g 4,6-diamino-5-phenylazopyrimidin (93,2%): U.V. (0,1N HCl)Amax = 365, E% = 773; smp: 298-300°C; ækv. vgt. (HCIO^) 218; tic, silicagel (CHCl^:Me0H 6:1, efter vol.): enkelt plet. Eksemplet viser, at andre ammoniumsalte er egnede til reaktionen.Example 1 is repeated as described with the change that ammonium acetate is added. After work-up in the same manner, 19.92 g of 4,6-diamino-5-phenylazopyrimidine (93.2%) is obtained: U.V. (0.1N HCl) Amax = 365, E% = 773; mp: 298-300 ° C; eq. weight. (HClO) 218; tic, silica gel (CHCl3: MeOH 6: 1, by vol.): single stain. The example shows that other ammonium salts are suitable for the reaction.

6 142875 EKSEMPEL 5EXAMPLE 5

Præparation af 4,6-diamino-5-pherryiazopyrimidinPreparation of 4,6-diamino-5-pherryiazopyrimidine

Eksempel 1 gentages som beskrevet med den ændring, at ammonium-iodid tilsættes. Efter oparbejdning på samme måde fås 19,20 g 4.6- diamino-5-phenylazopyrimidin (89,7%): U.V. (0,1 N HCl)7\,max = 365, E% = 817; smp: 299-302°C; ækv. vgt. (HC104) 213,8; tic, silicagel (CHCl^tMeOH 6:1, efter vol.): enkelt plet. Eksemplet viser, at andre ammoniumsalte er egnede til reaktionen.Example 1 is repeated as described with the change that ammonium iodide is added. After work-up in the same manner, 19.20 g of 4.6-diamino-5-phenylazopyrimidine (89.7%) are obtained: U.V. (0.1 N HCl) δ max, 365, E% = 817; mp: 299-302 ° C; eq. weight. (HClO 4) 213.8; tic, silica gel (CHCl3 tMeOH 6: 1, by vol.): single stain. The example shows that other ammonium salts are suitable for the reaction.

EKSEMPEL 6EXAMPLE 6

Præparation af 4,6-diamino-5-phenylazopyrimidinPreparation of 4,6-diamino-5-phenylazopyrimidine

Eksempel 1 gentages som beskrevet med den ændring, at ammoniumsulfat tilsættes. Efter oparbejdning på samme måde fås 19,6 g 4.6- diamino-5-phenylazopyrimidin (91,4%) : U.V. (0^1 N HC1) ^ max = 365, E% = 808; smp: 293-297°C; ækv. vgt. (HC104) 217,6; tic, silicagel (CHGl^:Me0H 6:1, efter vol.): enkelt plet. Eksemplet viser, at andre ammoniumsalte er egnede til reaktionen.Example 1 is repeated as described with the change that ammonium sulfate is added. After workup similarly, 19.6 g of 4.6-diamino-5-phenylazopyrimidine (91.4%) are obtained: U.V. (0 N 1 HCl) max = 365, E% = 808; mp: 293-297 ° C; eq. weight. (HClO 4) 217.6; tic, silica gel (CHGl4: MeOH 6: 1, by vol.): single stain. The example shows that other ammonium salts are suitable for the reaction.

EKSEMPEL 7-10EXAMPLES 7-10

Eksempel 1 gentages med den ændring, at reaktionen udføres ved forskellige temperaturer som angivet i følgende tabel:Example 1 is repeated with the change that the reaction is carried out at different temperatures as indicated in the following table:

Smp. Ækv. U.VMp. Eq. U.V

Eksempel Temp. Udbytte Udbytte ( C) vgt. (0, IN HCl) (V) (gram) (%) (HCIO4) l^max 365) 7 90 17,0 17,0 255-264 190,4 1090 8 120 18,5 86,5 252-259 206,7 863 9 250 13,2 61,8 299-305 214,8 785 10 25 Noget materiale ved tic.Example Temp. Yield Yield (C) weight. (0.N HCl) (V) (grams) (%) (HClO 4) max 365) 7 90 17.0 17.0 255-264 190.4 1090 8 120 18.5 86.5 252-259 206 , 7 863 9 250 13.2 61.8 299-305 214.8 785 10 25 Some material by tic.

7 1428757 142875

Tabellen viser, at reaktionen kan udføres under varierende temperaturbetingelser . Fortrinsvis ligger temperaturen i området fra 90°C til 250°C.The table shows that the reaction can be carried out under varying temperature conditions. Preferably, the temperature ranges from 90 ° C to 250 ° C.

EKSEMPEL 11EXAMPLE 11

Præparation af adenin fra 4,6-diamino-5-arvlazopyrimidin I en 300 ml autoklav indføres i rækkefølge 24 ml formamid (27 g, 0,6 mol), 21,42 g 4,6-diamino-5-phenylazopyrimidin (0,1 mol), 80 ml isopropanol og 240 mg 5% Pd/C. Apparatet lukkes, og der indføres hydrogen til et tryk på 84 kg/cm^, hvorpå der opvarmes til 200°C under rystning i 8 timer. Beholderen afkøles til stuetemperatur, og det lysegule adenin filtreres (alle overførsler sker med modervæsken). Filterkagen opløses i 50 ml 2N natriumhydroxidopløsning. Reduktionskatalysatoren frafiltreres, og filtratet neutraliseres til pH-værdi på 7,0. Det hvide adenin opsamles på en tragt og vaskes med 20 ml vand. Efter tørring i vakuum (100°C, 20 mmHg, 3 timer) fås 12,75 g adenin (udbytte 94,5%): U.V. (0,1 N HCl)Amax = 263, E% = 928; smp: 358°C, væske chroma to gr af i, vægt % adenin = 94,7% rent; tic, silicagel (CHCl^iMeOH 6:1 efter vol.): enkelt plet.Preparation of adenine from 4,6-diamino-5-arvlazopyrimidine In a 300 ml autoclave, 24 ml of formamide (27 g, 0.6 mol), 21.42 g of 4,6-diamino-5-phenylazopyrimidine (0, 1 mol), 80 ml of isopropanol and 240 mg of 5% Pd / C. The apparatus is closed and hydrogen is introduced to a pressure of 84 kg / cm 2, then heated to 200 ° C under shaking for 8 hours. The vessel is cooled to room temperature and the pale yellow adenine is filtered (all transfers are with the mother liquor). The filter cake is dissolved in 50 ml of 2N sodium hydroxide solution. The reduction catalyst is filtered off and the filtrate neutralized to pH 7.0. The white adenine is collected on a funnel and washed with 20 ml of water. After drying in vacuo (100 ° C, 20 mmHg, 3 hours), 12.75 g of adenine (yield 94.5%) is obtained: U.V. (0.1 N HCl) Amax = 263, E% = 928; mp: 358 ° C, liquid chroma two grams of i, wt% adenine = 94.7% pure; tic, silica gel (CHCl3 in MeOH 6: 1 by vol.): single stain.

EKSEMPEL 12EXAMPLE 12

Præparation af adenin uden isolation af 4,6-diamino-5-phenylazo-pyrimidin_ I en 300 ml autoklav indføres i rækkefølge 2,13 g ammoniumchlorid (0,04 mol), 17,0 g phenylazomalononitril (0,10 mol), 240 mg 5%Preparation of adenine without isolation of 4,6-diamino-5-phenylazo-pyrimidine In a 300 ml autoclave, 2.13 g of ammonium chloride (0.04 mol), 17.0 g of phenylazomalononitrile (0.10 mol), 240 mg 5%

Pd/C og 92 ml formamid, som indeholdt 12% ammoniak efter vægt. Apparatet rystes ved 150°C i 5 timer og fyldes derefter med hydro-gen ved et tryk på 84 kg/cm' . Efter henstand under rystning ved denne temperatur i yderligere 5 timer afkøles apparatet til stuetemperatur. Ved samme oparbejdningsmetode som beskrevet for adenin i eksempel 11 fås 10,8 g adenin (udbytte 80%) U.V. (0,1 N HCl) 7^ max = 263, = 900, smp: 355°C, L.C. vægt% adenin = 92% rent, tic enkelt plet.Pd / C and 92 ml of formamide containing 12% by weight ammonia. The apparatus is shaken at 150 ° C for 5 hours and then filled with hydrogen at a pressure of 84 kg / cm 2. After standing under shaking at this temperature for an additional 5 hours, the apparatus is cooled to room temperature. By the same reprocessing method as described for adenine in Example 11, 10.8 g of adenine (yield 80%) is obtained U.V. (0.1 N HCl) δ max = 263, = 900, mp: 355 ° C, L.C. weight% adenine = 92% pure, tic single spot.

DK171777A 1977-04-19 1977-04-19 Process for the preparation of adenine. DK142875B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK171777A DK142875B (en) 1977-04-19 1977-04-19 Process for the preparation of adenine.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK171777 1977-04-19
DK171777A DK142875B (en) 1977-04-19 1977-04-19 Process for the preparation of adenine.

Publications (3)

Publication Number Publication Date
DK171777A DK171777A (en) 1978-10-20
DK142875B true DK142875B (en) 1981-02-16
DK142875C DK142875C (en) 1981-09-21

Family

ID=8107480

Family Applications (1)

Application Number Title Priority Date Filing Date
DK171777A DK142875B (en) 1977-04-19 1977-04-19 Process for the preparation of adenine.

Country Status (1)

Country Link
DK (1) DK142875B (en)

Also Published As

Publication number Publication date
DK142875C (en) 1981-09-21
DK171777A (en) 1978-10-20

Similar Documents

Publication Publication Date Title
WO2015180585A1 (en) Method of producing thiamethoxam
KR100573859B1 (en) A process for preparing 9-[4-acetoxy-3-acetoxymethylbut-1-yl]-2-aminopurine
DK142875B (en) Process for the preparation of adenine.
Paula Freitas et al. Synthesis of 5‐azido‐4‐cyanoimidazole and its reaction with active methylene compounds
US6630593B1 (en) Process for preparing a 1-substituted 5-hydroxymethyl imidazole
US3886176A (en) Process for preparing imidazole-4,5-dicarboxamide
KR20080049197A (en) Improved process for preparing cis-di(thiocyanato)-n,n'-bis(2,2'-bipyridyl-4,4'-dicarboxylic acid)ruthenium(ii)
US5686618A (en) Method for preparing 3-amino-2-chloro-4-alkylpyridine or-4-arylpyridine
HU198179B (en) Process for producing n-methyl-1-alkylthio-2-nitroethenamine derivatives
EP2303855A2 (en) Catalytic process for asymmetric hydrogenation
NO312593B1 (en) Process for preparing a deoxyuridine derivative
CA2508341A1 (en) Processes for preparing quinolonecarboxylate derivatives
US3494921A (en) 1,4-disubstituted pyridazino(4,5-d) pyridazines
SU598900A1 (en) Method of obtaining derivatives of 8-azaxanthine
SU1011644A1 (en) Process for preparing 1-alkyl-4-nitroimidazoles
EP0054892B1 (en) Synthesis of indolines
US4992568A (en) Synthesis of benzofurans
US5688947A (en) Production of purines via reductive formylation
RU2238272C1 (en) Method for preparing 1-alkyl-6,6-dimethyl-2,4-dioxo-2,3,4,5,6,7-hexahydro-1h-indole-3-spiro-2-( 1-aryl-3-aroyl-4-hydroxy-5-oxo-2,5-dihydropyrrols)
JPS6396175A (en) Manufacture of 2,4-diamino-3-oxy-6- piperidylpyrimidine
US5169955A (en) Process for producing 2-hydroxyquinoxaline derivatives
US4225719A (en) Process for preparing 2-amino-5-formylthiazole and its hydrobromide salt
IE45046B1 (en) Method of producing 5-fluorouracil derivatives
Bobkov et al. Reaction of 8-bromotheophylline with pyridine and alkylpyridines. 8-Pyridiniotheophyllinates
SU463672A1 (en) The method of obtaining hypoxanthine or adenine

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed